<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>School of Biological Sciences</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C6BA4704-49F5-4934-9FA0-DB5C78E8314C"><gtr:id>C6BA4704-49F5-4934-9FA0-DB5C78E8314C</gtr:id><gtr:firstName>Andreas</gtr:firstName><gtr:surname>Wyttenbach</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G120%2F881"><gtr:id>6D96997B-B23A-47BB-B6C7-45D3D8E9B3B9</gtr:id><gtr:title>The role of reactive oxygen species (ROS) during protein aggregation and neuronal death in polyglutamine diseases</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G120/881</gtr:grantReference><gtr:abstractText>There is substantial nerve cell loss in brains of patients suffering from neurodegenerative disorders such as Alzheimer?s disease, Parkinson?s disease and the polyglutamine diseases. In each disease, unknown environmental factors and genetic mutations cause specific proteins to form insoluble protein aggregates that are associated with the loss of neurons. Neuronal loss significantly contributes to pathology. In order to develop strategies that prevent neuronal loss, it is therefore crucial to understand the mechanisms that cause neuronal damage and death due to protein aggregation. A key factor affecting protein aggregation and neuronal death is oxidative stress due to the production of reactive oxygen species (ROS). Using cellular models of Huntington?s disease (HD), the most prevalent polyglutamine disease, I found that aggregation prone polyglutamine proteins induce ROS and that heat shock proteins are potent antagonists of polyglutamine induced ROS and death. The aim of this proposal is to understand the relationship between protein aggregation, ROS production and neuronal death using cellular and mouse models of HD. Furthermore, I aim to study the neuroprotective roles of heat shock proteins (HSPs) and kinases, key regulators of ROS and neuronal death. This study may lead to the identification of important regulators of neuronal death that could be targeted for therapeutic intervention and prevention of neuronal loss.</gtr:abstractText><gtr:technicalSummary>Alzheimer?s disease, Parkinson?s disease and the polyglutamine (polyQ) diseases are characterized by a loss of neurones. At least nine polyQ diseases are caused by CAG expansions in unrelated genes. CAG expanded polyQ proteins aggregate within neurones and promote neuronal death. The mechanisms of neuronal death are poorly understood. Recently, it has become clear that oxidative stress (production of reactive oxygen species/ROS) contributes significantly to neurodegeneration in Huntington?s disease (HD), the most studied polyQ disease. My research on cellular models of HD showed that polyQ expansions induce intracellular ROS and I identified heat shock protein (HSP)27 as a suppressor of ROS and polyQ death. However, it is unknown how polyQ expanded proteins cause oxidative stress, how this contributes to neuronal loss and how HSPs and associated kinases modulate neuronal death. This proposal aims to answer these questions using cellular/animal models of HD and human HD postmortem brain tissue. These studies will clarify the role of oxidative stress/free radicals during polyQ pathology/death and elucidate new neuroprotective mechanisms of kinases and HSPs.
 
Mitochondria are the key source of ROS within cells, play pivotal roles during neuronal death and are dysfunctional in HD. Hence, to identify how polyQ expansions induce oxidative stress, I will test if mitochondria produce ROS abnormally due to polyQ toxicity. I will directly measure ROS within living primary neurons expressing adenovirus-mediated polyQ expanded proteins and analyse ROS production of isolated mitochondria. Mitochondria will be co-incubated with toxic and control polyQ peptides to test if a direct interaction occurs that promotes ROS production. Mitochondria obtained from HD mouse models at specific stages during pathology will also be investigated. If mitochondria are not responsible for increased ROS production I will test if increased ROS is due to impaired anti-oxidant systems using nl cell models of HD. Because polyQ oligomerization is pivotal for induction of toxicity, I will investigate if polyQ oligomerization is central to mediating oxidative stress using aggregation inhibitors (Congo Red). I will then relate specific neuronal cell death markers to the effects of oxidative stress in time course studies using striatal neuronal culture. I will further explore the role of HSP27 in polyQ pathology by monitoring changes in expression and phosphorylation of this protein in HD transgenic mouse and human postmortem brain and by analysing/inhibiting upstream signalling components with special emphasis on p38 mitogen-activated protein kinases (that regulate HSP27) in HD cell models. These studies will establish how polyQ, ROS and HSP27 are causally connected, and clarify how their production/impairment leads to neuronal cell death.</gtr:technicalSummary><gtr:fund><gtr:end>2009-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>500493</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>38F18BA7-BA8F-4C72-9674-2A13CC1792FB</gtr:id><gtr:title>Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38061e9536e035183d46dff2852fd162"><gtr:id>38061e9536e035183d46dff2852fd162</gtr:id><gtr:otherNames>King MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>FFB46CA86EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>735D6CCD-3E6D-4C2D-89BC-D0A0D39A4BAA</gtr:id><gtr:title>Neurotoxic protein oligomerisation associated with polyglutamine diseases.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0113eb644b7e120fdfaf025bfaca8af"><gtr:id>f0113eb644b7e120fdfaf025bfaca8af</gtr:id><gtr:otherNames>Hands SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>qxrUGDbodT6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D1898FB-8E64-4F5E-9940-6E61F93890D9</gtr:id><gtr:title>Huntingtin inclusion bodies are iron-dependent centers of oxidative events.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f35d7ac576572499e22680ae6e38944f"><gtr:id>f35d7ac576572499e22680ae6e38944f</gtr:id><gtr:otherNames>Firdaus WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>28E42C8B968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EAC2228-5638-49E6-A4EF-8B5A95952115</gtr:id><gtr:title>Expression of the small heat shock protein family in the mouse CNS: differential anatomical and biochemical compartmentalization.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f21b62205d2ceaedee842e974727f2bc"><gtr:id>f21b62205d2ceaedee842e974727f2bc</gtr:id><gtr:otherNames>Quraishe S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>DA771EB8D29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F96BC161-C3C6-421A-A070-28DB24A3F40A</gtr:id><gtr:title>Analysis of oxidative events induced by expanded polyglutamine huntingtin exon 1 that are differentially restored by expression of heat shock proteins or treatment with an antioxidant.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f35d7ac576572499e22680ae6e38944f"><gtr:id>f35d7ac576572499e22680ae6e38944f</gtr:id><gtr:otherNames>Firdaus WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>6DCD93B5D84</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A90A0BE-747B-400A-90FE-499BF8127212</gtr:id><gtr:title>Heat shock proteins: therapeutic drug targets for chronic neurodegeneration?</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c9e7874ce39399bde3bc077cf93b18b"><gtr:id>4c9e7874ce39399bde3bc077cf93b18b</gtr:id><gtr:otherNames>Sajjad MU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1389-2010</gtr:issn><gtr:outcomeId>WAwZVnemNKB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6897F8D8-B4AF-49D8-BD4D-43C109AB9E1E</gtr:id><gtr:title>Amelioration of protein misfolding disease by rapamycin: translation or autophagy?</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f6abb271a91b1687c03d14eafcb9d8"><gtr:id>03f6abb271a91b1687c03d14eafcb9d8</gtr:id><gtr:otherNames>Wyttenbach A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>216B9C9FF97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D65F0D09-73DF-443A-B39F-CC444321D836</gtr:id><gtr:title>Increased throughput assays of locomotor dysfunction in Drosophila larvae.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76b23cc82bad7cc641dd923a5c585731"><gtr:id>76b23cc82bad7cc641dd923a5c585731</gtr:id><gtr:otherNames>Sinadinos C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>fci6hzhaEWX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CB1F3B8-BF71-4EF6-8BB6-656434357224</gtr:id><gtr:title>Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76b23cc82bad7cc641dd923a5c585731"><gtr:id>76b23cc82bad7cc641dd923a5c585731</gtr:id><gtr:otherNames>Sinadinos C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>82D0E3AE8DB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81D1D2AF-11A7-4054-B2E9-666C7E8FCA90</gtr:id><gtr:title>Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0113eb644b7e120fdfaf025bfaca8af"><gtr:id>f0113eb644b7e120fdfaf025bfaca8af</gtr:id><gtr:otherNames>Hands SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>RXFps38u4Gr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24A6ADAA-47D9-46C4-8BD7-5489615E30A9</gtr:id><gtr:title>In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09e255984cb4036768cf2310b546260e"><gtr:id>09e255984cb4036768cf2310b546260e</gtr:id><gtr:otherNames>Hands S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>tUU581haaTy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82FE1C31-1955-4D54-8D9A-B7ED2A039150</gtr:id><gtr:title>Polyglutamine gene function and dysfunction in the ageing brain.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09e255984cb4036768cf2310b546260e"><gtr:id>09e255984cb4036768cf2310b546260e</gtr:id><gtr:otherNames>Hands S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>33F4113675B</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G120/881</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>